Inpharma Weekly

, Volume 881, Issue 1, pp 6–6 | Cite as

Nilutamide - compliance attractive in prostate cancer

Newsletter Article


Prostate Cancer Testosterone Androgen Androgen Receptor Objective Response Rate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 1993

Personalised recommendations